We see that javascript is disabled or not supported by your browser - javascript is needed for important actions on the site. Read more

What's New - Home - Login

Member $avings: $81,596,552.11 | Books Available: 785,506 | Members Online: 108

Swap Used Books - Buy New Books at Great Prices!

How To Swap Books Sign Up Search submenu

PBS Market (New Books)

Gift Buying Guide

Book Browser Advanced Search Books Posted Today Member Book Reviews Award Winning Books NYT Best Sellers Amazon Best Sellers Most Traveled Copies Club Wish List

Discussion Forums Book Lists

Club Lists My Book Lists My Watched Lists Create a List

Blog Donations

School Donation Program In Memory of... Military Donation Program Friends of PBS

Box-O-Books Maps The Eclectic Pen Fun Stuff

20 Questions Sudoku Bookmark Creator

Top 100

Requests Posts Swappers Referrers Reviewers

Pulse of PBS Spread The Word

Invite Friends Bookmarks Facebook Page Facebook App More Ways...

Photo Gallery Recipes Club Tag Cloud Member Testimonials

Help Center submenu

How To Swap Books Browse Help Docs Ask the Librarian PBS Member Icons Live Help

Kiosk

PBS Market (New Books) Go Shopping Buy Credits Buy PBS Money Upgrade Membership Gift Certificates Transfer Credits

Need Help?

Search - An Analytic Assessment of US Drug Policy (Aei Evaluative Studies)

An Analytic Assessment of US Drug Policy - Aei Evaluative Studies
Author: David Boyum

In its efforts to control the use of cocaine, heroin, marijuana, and other illegal drugs, the United States spends about $35 billion per year in public funds. Almost half a million dealers and users are under incarceration. In this book, David Boyum and Peter Reuter provide an assessment of how well this massive investment of tax dollars and gov... more »ernment authority is working. Boyum and Reuter show that America's drug problem is mainly a legacy of the epidemics of heroin, cocaine, and crack use during the 1970s and 1980s, which left us with aging cohorts of criminally active and increasingly sick users. Newer drugs, such as Ecstasy and methamphetamine, perennially threaten to become comparable problems, but so far have not. Using a market framework, the book discusses the nature and effectiveness of efforts to tackle the nation's drug problems. Drug policy has become increasingly punitive, with the number of drug offenders in jail and prison growing tenfold between 1980 and 2003. Nevertheless, there is strikingly little evidence that tougher law enforcement can materially reduce drug use. By contrast, drug treatment services remain in short supply, even though research indicates that treatment expenditures easily pay for themselves in terms of reduced crime and improved productivity. Boyum and Reuter conclude that America's drug policy should be reoriented in several ways to be more effective. Enforcement should focus on reducing drug-related problems, such as violence associated with drug markets, rather than on locking up large numbers of low-level dealers. Treatment services for heavy users, particularly methadone and other opiate maintenance therapies, need more money and fewer regulations. And programs that coerce convicted drug addicts to enter treatment and maintain abstinence as a condition of continued freedom should be expanded. The AEI Evaluative Studies series aims to promote greater understanding and continuing review of major activities of the federal government. Each study focuses on a government program or policy in operation by examining its purposes, administration, costs, and effectiveness and then recommends practical reforms for improved performance. David Boyum is an independent consultant in New York City. Peter Reuter is a professor at the University of Maryland and a senior economist in the Drug Policy Research Center at RAND.

ISBN-13: 9780844741918
ISBN-10: 0844741914
Publication Date: 3/25/2005
Pages: 133
Edition: New title
Rating:

0 stars, based on 0 rating

Publisher: AEI Press
Book Type: Paperback
Members Wishing: 0
Reviews: Amazon | Write a Review

Genres:

Back to the Top ↑

Search - An Analytic Assessment of US Drug Policy (Aei Evaluative Studies)

Loading...